Madagascar has a small population and a low malaria burden. The country has a highly regulated market with strong public and community-based provision of antimalarials.  As an isolated island nation, the results of policy change are seen more quickly and are less affected by the policy/subsidy interventions implemented in neighbouring countries. The AMFm subsidy was piloted in Madagascar from 2010-2013.

As of 2016, ACTwatch has conducted five outlet surveys (2008 2010, 2011, 2013 and 2015), two household surveys (2009 and 2012) as well as qualitative and quantitative supply chain research (2012) in Madagascar. The 2013/2014 outlet survey is available in French here. The results from the 2015 outlet survey will be available soon.